The SLC39A1‐DRP1 axis: A paradigm shift in targeting mitochondrial dynamics for HCC therapy

Authors

Dengke Bao (ORCID: https://orcid.org/0000-0002-6503-934X)
Jing Zhao (ORCID: https://orcid.org/0009-0003-4124-2030)

Institutions

Henan University of Engineering (CN)

Publication Details

Journal: Clinical and Translational Discovery
Published: 2025-08-31
DOI: https://doi.org/10.1002/ctd2.70074
Primary Topic: Cancer, Hypoxia, and Metabolism
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

The SLC39A1‐DRP1 axis: A paradigm shift in targeting mitochondrial dynamics for HCC therapy

Dengke Bao, Jing Zhao

Aug 31, 2025

Clinical and Translational Discovery

Cancer, Hypoxia, and Metabolism

article

The SLC39A1‐DRP1 axis: A paradigm shift in targeting mitochondrial dynamics for HCC therapy

Dengke Bao, Jing Zhao

August 31, 2025article en

Abstract

No abstract available for this paper.

Clinical and Translational DiscoveryVol. 5(5)

Henan University of Engineering (CN)

Openalex Percentile: Top 71%

Cancer, Hypoxia, and Metabolism

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The SLC39A1‐DRP1 axis: A paradigm shift in targeting mitochondrial dynamics for HCC therapy — Dengke Bao, Jing Zhao · Clinical and Translational Discovery (2025) | TGRS Research Map | TGRS